We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

November 13, 2008

Pozen Inc. v. Par Pharmaceutical, Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. August 8, 2011

    Pozen Wins Injunction On Generic Treximet

    A Texas federal judge ruled Friday that Par Pharmaceutical Cos. Inc. and two other drugmakers had infringed Pozen Inc.'s patents covering the migraine treatment Treximet and barred them from selling generic versions of the drug in the U.S. until certain patents expire.

1 other articles on this case. View all »


To view the parties, register now.